Picture of Synairgen logo

SNG — Synairgen Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Synairgen, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-17.7-57.9-20.1-9.66-7.93
Depreciation
Amortisation
Non-Cash Items0.1980.4950.7120.1550.024
Other Non-Cash Items
Changes in Working Capital-6.5416.24.991.20.062
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-23.8-41-14.3-8.22-7.81
Capital Expenditures-0.076-0.033-0.006-0.082-0.106
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0310.012-3.612.891.94
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.045-0.021-3.622.811.83
Financing Cash Flow Items-3.2-0.0020——
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities96.4-0.1120.00100.013
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash72.5-41.1-17.9-5.41-5.96